科研速递论坛

标题: OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients... [打印本页]

作者: 翔子 时间: 2016-9-21 14:28
标题: OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients...

题名	OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study
链接	http://ard.bmj.com/content/74/Suppl_2/75.3

Ann Rheum Dis 2015;74:75-76 doi:10.1136/annrheumdis-2015-eular.1427

作者: xujdai 时间: 2016-9-21 14:28
https://yunpan.cn/ck6WDFerUWG2J 访问密码 8fd3

欢迎光临科研速递论坛 (http://expaper.cn/)